See and treat
MRI-guided Stereotactic Ablative Radiotherapy (SABR) is a new paradigm in radiotherapy treatment, allowing real-time adaptive treatment of tumours that move or are difficult to reach. It is transforming the standard of care for difficult-to-reach tumours and oligometastatic disease. Our client, GenesisCare, is the first in the UK to offer MRIdian MRI-guided treatment outside research use.
A content campaign engages and educates surgeons, medical oncologists and radiation oncologists. These are some of the outputs.
This omnichannel content campaign included:
Summarising and presenting published studies, to support evidence-based protocols.
Working with clinicians to develop and share real-world examples of care
Dedicated HCP web pages, including educational resources and referral support
Case studies, new study evidence data and downloadable assets
A suite of e-brochures for use by the sales teams
GenesisCare is an established centre of excellence for MRIdian MR-guided radiotherapy. Their clinicians are recognised as KOLs and are supported with a rich and continuous source of high-quality clinical and educational content.